_version_ 1797259926086615040
author Aviya Lanis, MD
Hanna Kim, MD, MS
Shajia Lu, BS
Wanxia Li Tsai, MS
Amy Kaneshiro, BA
Alison Ehrlich, MD, MHS
George Martin, MD
Adam Schiffenbauer, MD
Susan Shenoi, MBBS, MS, RhMSUS
author_facet Aviya Lanis, MD
Hanna Kim, MD, MS
Shajia Lu, BS
Wanxia Li Tsai, MS
Amy Kaneshiro, BA
Alison Ehrlich, MD, MHS
George Martin, MD
Adam Schiffenbauer, MD
Susan Shenoi, MBBS, MS, RhMSUS
author_sort Aviya Lanis, MD
collection DOAJ
first_indexed 2024-03-08T02:00:44Z
format Article
id doaj.art-527fdc2cdcb94a879ba8e73ddb2e4c60
institution Directory Open Access Journal
issn 2352-5126
language English
last_indexed 2024-04-24T23:17:11Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series JAAD Case Reports
spelling doaj.art-527fdc2cdcb94a879ba8e73ddb2e4c602024-03-17T07:54:43ZengElsevierJAAD Case Reports2352-51262024-03-01452426Efficacy of topical ruxolitinib for cutaneous dermatomyositisAviya Lanis, MD0Hanna Kim, MD, MS1Shajia Lu, BS2Wanxia Li Tsai, MS3Amy Kaneshiro, BA4Alison Ehrlich, MD, MHS5George Martin, MD6Adam Schiffenbauer, MD7Susan Shenoi, MBBS, MS, RhMSUS8Department of Pediatric Rheumatology, Seattle Children’s Hospital, University of Washington, Seattle, Washington; Correspondence to: Aviya Lanis, MD, Department of Pediatric Rheumatology, Seattle Children’s Hospital, University of Washington, MA 7.110, 4800 Sand Point Way NE, Seattle, WA 98105.Juvenile Myositis Pathogenesis and Therapeutics Unit, Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MarylandTranslational Immunology Section, Office of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MarylandTranslational Immunology Section, Office of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MarylandJuvenile Myositis Pathogenesis and Therapeutics Unit, Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MarylandEnvironmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, Bethesda, MarylandDr. George Martin Dermatology Associates, Kihei, HawaiiEnvironmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health, Bethesda, MarylandDepartment of Pediatric Rheumatology, Seattle Children’s Hospital, University of Washington, Seattle, Washingtonhttp://www.sciencedirect.com/science/article/pii/S2352512623004277dermatomyositispediatric rheumatic diseaseruxolitinib
spellingShingle Aviya Lanis, MD
Hanna Kim, MD, MS
Shajia Lu, BS
Wanxia Li Tsai, MS
Amy Kaneshiro, BA
Alison Ehrlich, MD, MHS
George Martin, MD
Adam Schiffenbauer, MD
Susan Shenoi, MBBS, MS, RhMSUS
Efficacy of topical ruxolitinib for cutaneous dermatomyositis
JAAD Case Reports
dermatomyositis
pediatric rheumatic disease
ruxolitinib
title Efficacy of topical ruxolitinib for cutaneous dermatomyositis
title_full Efficacy of topical ruxolitinib for cutaneous dermatomyositis
title_fullStr Efficacy of topical ruxolitinib for cutaneous dermatomyositis
title_full_unstemmed Efficacy of topical ruxolitinib for cutaneous dermatomyositis
title_short Efficacy of topical ruxolitinib for cutaneous dermatomyositis
title_sort efficacy of topical ruxolitinib for cutaneous dermatomyositis
topic dermatomyositis
pediatric rheumatic disease
ruxolitinib
url http://www.sciencedirect.com/science/article/pii/S2352512623004277
work_keys_str_mv AT aviyalanismd efficacyoftopicalruxolitinibforcutaneousdermatomyositis
AT hannakimmdms efficacyoftopicalruxolitinibforcutaneousdermatomyositis
AT shajialubs efficacyoftopicalruxolitinibforcutaneousdermatomyositis
AT wanxialitsaims efficacyoftopicalruxolitinibforcutaneousdermatomyositis
AT amykaneshiroba efficacyoftopicalruxolitinibforcutaneousdermatomyositis
AT alisonehrlichmdmhs efficacyoftopicalruxolitinibforcutaneousdermatomyositis
AT georgemartinmd efficacyoftopicalruxolitinibforcutaneousdermatomyositis
AT adamschiffenbauermd efficacyoftopicalruxolitinibforcutaneousdermatomyositis
AT susanshenoimbbsmsrhmsus efficacyoftopicalruxolitinibforcutaneousdermatomyositis